Bahl & Gaynor Inc. boosted its position in CONMED Co. (NYSE:CNMD – Free Report) by 1.4% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 15,434 shares of the company’s stock after purchasing an additional 207 shares during the period. Bahl & Gaynor Inc.’s holdings in CONMED were […]